BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
2.035
+0.005 (0.25%)
Sep 4, 2026, 11:17 AM EDT - Market open

BioVie Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-22.07-17.54-32.12-50.26-26.08
Depreciation & Amortization
0.180.230.230.230.23
Other Amortization
-0.010.110.170.1
Loss (Gain) From Sale of Investments
---0.22--
Stock-Based Compensation
2.872.474.666.386.19
Other Operating Activities
0.080.2-0.513.5-2.18
Change in Accounts Receivable
-0.05-2.1---
Change in Accounts Payable
1.5-1.390.111.031.45
Change in Other Net Operating Assets
-1.54-0.91-0.2-1.31.3
Operating Cash Flow
-19.02-19.03-27.95-40.25-18.99
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Investment in Securities
--14.53-14.3-
Investing Cash Flow
--14.53-14.3-

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Long-Term Debt Issued
----14.61
Total Debt Issued
----14.61
Long-Term Debt Repaid
--5.85---
Total Debt Repaid
--5.85---
Net Debt Issued (Repaid)
--5.85--14.61
Issuance of Common Stock
10.4618.5827.855.3718.51
Other Financing Activities
---10--
Financing Cash Flow
10.4612.7317.855.3733.12

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash Flow
-8.57-6.34.380.8214.13

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Levered Free Cash Flow
-11.12-13.13-18.78-22.84-8.77
Unlevered Free Cash Flow
-11.11-12.93-17.08-20.32-7.52

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
0.020.181.532.110.96
Change in Working Capital
-0.08-4.4-0.09-0.272.75
SEC Filings: 10-K · 10-Q